132 related articles for article (PubMed ID: 3600950)
1. Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging.
Morgan DG; Marcusson JO; Nyberg P; Wester P; Winblad B; Gordon MN; Finch CE
Neurobiol Aging; 1987; 8(3):195-201. PubMed ID: 3600950
[TBL] [Abstract][Full Text] [Related]
2. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
3. Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the rhesus monkey (Macaca mulatta).
Lai H; Bowden DM; Horita A
Neurobiol Aging; 1987; 8(1):45-9. PubMed ID: 3561665
[TBL] [Abstract][Full Text] [Related]
4. Age-correlated loss of dopaminergic binding sites in human basal ganglia.
Severson JA; Marcusson J; Winblad B; Finch CE
J Neurochem; 1982 Dec; 39(6):1623-31. PubMed ID: 7142992
[TBL] [Abstract][Full Text] [Related]
5. Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: localization to intrinsic neurons and not to neocortical afferents.
Joyce JN; Marshall JF
Neuroscience; 1987 Mar; 20(3):773-95. PubMed ID: 2955247
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor density remains constant in treated Parkinson's disease.
Guttman M; Seeman P; Reynolds GP; Riederer P; Jellinger K; Tourtellotte WW
Ann Neurol; 1986 May; 19(5):487-92. PubMed ID: 2940960
[TBL] [Abstract][Full Text] [Related]
7. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--III. The effects of lesions in the parafascicular-intralaminar nuclei on D2 dopamine receptors and high affinity dopamine uptake.
Kilpatrick IC; Jones MW; Pycock CJ; Riches I; Phillipson OT
Neuroscience; 1986 Nov; 19(3):991-1005. PubMed ID: 2948134
[TBL] [Abstract][Full Text] [Related]
8. Increased brain dopamine and dopamine receptors in schizophrenia.
Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
[TBL] [Abstract][Full Text] [Related]
9. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D-1 receptors in the parkinsonian brain.
Rinne JO; Rinne JK; Laakso K; Lönnberg P; Rinne UK
Brain Res; 1985 Dec; 359(1-2):306-10. PubMed ID: 2934111
[TBL] [Abstract][Full Text] [Related]
11. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
Camus A; Javoy-Agid F; Dubois A; Scatton B
Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352
[TBL] [Abstract][Full Text] [Related]
13. Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen.
Brené S; Lindefors N; Herrera-Marschitz M; Persson H
Exp Brain Res; 1990; 83(1):96-104. PubMed ID: 2150048
[TBL] [Abstract][Full Text] [Related]
14. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
[TBL] [Abstract][Full Text] [Related]
15. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
Bird ED; Iversen LL
Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
[No Abstract] [Full Text] [Related]
16. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
Murrin LC; Gale K; Kuhar MJ
Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
[TBL] [Abstract][Full Text] [Related]
17. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds GP; Tourtellotte WW
Science; 1984 Aug; 225(4663):728-31. PubMed ID: 6147018
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent decline in human brain dopamine D1 and D2 receptors.
Rinne JO; Lönnberg P; Marjamäki P
Brain Res; 1990 Feb; 508(2):349-52. PubMed ID: 2407314
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
Seeman P; Chau-Wong M; Tedesco J; Wong K
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
[TBL] [Abstract][Full Text] [Related]
20. Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen.
Allard P; Marcusson JO
Neurobiol Aging; 1989; 10(6):661-4. PubMed ID: 2628776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
